The UPR-PERK pathway is not a promising therapeutic target for mutant SOD1-induced ALS

Yulia Dzhashiashvili, Chase P. Monckton, Harini S. Shah, Rejani B. Kunjamma, Brian Popko*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'The UPR-PERK pathway is not a promising therapeutic target for mutant SOD1-induced ALS'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

INIS

Neuroscience